Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Nov 18, 2020 $1.45 $1.49 $1.44 $1.46 170 755
Nov 17, 2020 $1.49 $1.50 $1.45 $1.50 112 935
Nov 16, 2020 $1.51 $1.54 $1.49 $1.49 177 435
Nov 13, 2020 $1.52 $1.52 $1.46 $1.52 325 815
Nov 12, 2020 $1.48 $1.55 $1.47 $1.50 113 512
Nov 11, 2020 $1.53 $1.56 $1.45 $1.47 120 712
Nov 10, 2020 $1.55 $1.56 $1.49 $1.52 88 361
Nov 09, 2020 $1.52 $1.54 $1.48 $1.52 159 199
Nov 06, 2020 $1.59 $1.59 $1.50 $1.52 180 780
Nov 05, 2020 $1.58 $1.66 $1.58 $1.61 129 155
Nov 04, 2020 $1.60 $1.61 $1.52 $1.59 73 283
Nov 03, 2020 $1.54 $1.60 $1.50 $1.59 70 916
Nov 02, 2020 $1.48 $1.56 $1.48 $1.52 92 735
Oct 30, 2020 $1.55 $1.55 $1.44 $1.51 166 862
Oct 29, 2020 $1.57 $1.59 $1.40 $1.51 120 975
Oct 28, 2020 $1.56 $1.57 $1.51 $1.52 136 350
Oct 27, 2020 $1.61 $1.64 $1.59 $1.59 99 385
Oct 26, 2020 $1.70 $1.71 $1.58 $1.61 125 450
Oct 23, 2020 $1.68 $1.73 $1.65 $1.71 136 472
Oct 22, 2020 $1.64 $1.75 $1.64 $1.69 121 524
Oct 21, 2020 $1.69 $1.72 $1.62 $1.63 180 112
Oct 20, 2020 $1.73 $1.73 $1.68 $1.68 150 061
Oct 19, 2020 $1.76 $1.76 $1.69 $1.71 180 668
Oct 16, 2020 $1.77 $1.77 $1.69 $1.70 90 727
Oct 15, 2020 $1.72 $1.75 $1.65 $1.75 174 042
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT